Últimas noticias sobre Option Care Health (NASDAQ:OPCH) Bolsa

Option Care Health

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.

Option Care Health Inc

Billionaire Elon Musk previously sold all his homes so he could live a more minimalistic life, moving to Texas to be closer to his many <a href="https://www.benzinga.com/news/24/07/39804744/spacex-x-to-move-headquarters-from-california-to-texas-musk-calls-it-the-final-straw-criticizes-gov">business operations there.</a>
Musk is now looking to build a secret compound for his kids and their mothers, according to a new report.
What Happened: Musk has <a href="https://www.benzinga.com/general/education/24/06/39547388/happy-birthday-elon-musk-53-facts-and-figures-about-tesla-spacex-ceo-on-his-53rd-birthday">fathered 12 children</a> with three different women and his new plans could be to have his children live close to each other to maximize his time with them as he remains a busy man running several companies.
Musk has bought several properties near each other in the Austin, Texas, area, according to a <a href="https://www.nytimes.com/2024/10/29/business/elon-musk-children-compound.html?partner=slack&amp;smid=sl-share">report </a>from the New York Times.
Included in the properties is a 14,400-square-foot home that could be the centerpiece of a planned family compound. Behind the larger property is a smaller six-bedroom mansion.
Musk spent $35 million for the two properties according to the report. The billionaire stays at a third mansion, which he can reach in a short 10-minute walk.
Shivon Zilis, who is an executive at Musk's Neuralink, moved into one of the houses with her children, according to the report. Musk and Zilis have three children together, twins Strider and Azure born in November 2021, and a child born in 2024, whose name has not been revealed.
While one mother of some of Musk's kids is supportive of the idea, another hasn't been supportive. Claire Boucher, better known as musician Grimes, is in a legal fight with Musk currently. Musk and Grimes have three children together.
Musk's first wife Justine Musk is the other mother of his children and the report did not say if she was receptive to the idea of a family compound. Musk and his first wife had six children together, with five living and one having previously passed away at the age of 10 months.
One of the five living children with his first wife is transgender and changed her legal name, distancing herself from her father.
Operations for Tesla, SpaceX and X can all be found in Texas, where Musk now spends a good portion of his time.
You may not be a billionaire like Elon Musk, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/general/entertainment/24/10/41187322/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">check out five </a><a href="https://www.benzinga.com/real-estate/reit/24/10/41549488/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">stocks </a><a href="https://www.benzinga.com/general/entertainment/24/10/41187322/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">flying under the radar that deserve your attention.</a>
Why It's Important: Musk's real estate purchases come as he has for years talked <a href="https://www.benzinga.com/news/24/06/39443823/elon-musk-once-said-collapsing-birth-rate-is-the-biggest-danger-civilization-faces-he-has-fathered-1">about declining birthrates</a> and encouraged people to have as many children as possible to save humankind.
"It should be considered a national emergency to have kids," Musk said previously in June 2024.
Musk is supportive of in-vitro fertilization (IVF), which was used for several of his children. The billionaire has also volunteered donating sperm to at least one person to father more children, according to the report.
The real estate dealings of Musk have drawn increased interest from the press and the <a href="https://www.benzinga.com/news/23/09/34743808/elon-musk-glass-house-case-sees-justice-department-looking-into-personal-benefits-from-tesla-the-lat">U.S. Department of Justice (DOJ) previously.</a>
Musk was reported <a href="https://www.benzinga.com/news/23/07/33200386/did-elon-musk-have-a-secret-glass-house-project-in-texas-new-report-looks-into-project-42">building a secret glass house</a> several years ago, which he denied. The DOJ launched an investigation into whether the house was using resources from Tesla.
Around the same time of the investigation, Musk was said to begin touring Austin looking for homes and later lived in a 6,900-square-foot house in the area with Boucher. The billionaire got the idea of buying more property near that home to start the family compound.
Musk is currently the richest person in the world worth an estimated $270 billion by <a href="https://www.bloomberg.com/billionaires/?sref=TBDibEcD">Bloomberg</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/23/02/30928396/elon-musk-the-landlord-tesla-ceo-might-be-bringing-houses-to-employees-with-this-company">Elon Musk, The Landlord? Tesla CEO Might Be Bringing Houses To Employees With This Company</a></li>
</ul>
Photo: Elon Musk and Grimes (Claire Boucher), Photo by Sky Cinema on Shutterstock

Entertainment

Real Estate

Elon Musk Want His 11 Kids, Their Mothers To Live In Secret Compound He Bought, New Report Says

Buenaventura Mining Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BVN#NYSE">BVN</a>) reported quarterly earnings of $0.93 per share. The company reported quarterly sales of $331.100 million which beat the analyst consensus estimate of $263.025 million by 25.88 percent. This is a 56.70 percent increase over sales of $211.300 million the same period last year.

Earnings

Earnings Beats

News

Buenaventura Mining Co Q3 2024 GAAP EPS $0.93, Sales $331.100M Beat $263.025M Estimate

Editor&#8217;s Note: The fourth-quarter revenue estimate was corrected. 
Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) reported third-quarter financial results after the market close on Wednesday. Here&#8217;s everything <a href="https://www.benzinga.com/pressreleases/24/10/n41635757/meta-reports-third-quarter-2024-results">you need to know from the quarter</a>.
Q3 Earnings: Meta reported third-quarter revenue of $40.59 billion, beating&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst estimates</a>&nbsp;of $40.29 billion. The company reported third-quarter adjusted earnings of $6.03 per share, beating analyst estimates of $5.25 per share.
Meta has now beat analyst estimates on the top and bottom lines in seven consecutive quarters, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 19% on a year-over-year basis. Family daily active people were up 5% year-over-year to 3.29 billion. Ad impressions jumped 7% year-over-year and average price per ad increased by 11% year-over-year.
Costs and expenses came in at $23.24 billion, up 14% year-over-year. Capital expenditures came in at $9.2 billion. The company ended the quarter with $70.9 billion in cash, cash equivalents and marketable securities, and $28.82 billion of long-term debt.
Meta noted that its headcount was up 9% year-over-year to 72,404 as of Sept. 30.
&#8220;We had a good quarter driven by AI progress across our apps and business,&#8221; said&nbsp;Mark Zuckerberg, founder and CEO of Meta. &#8220;We also have strong momentum with Meta AI, Llama adoption, and AI-powered glasses.&#8221;
Related Link: <a href="https://www.benzinga.com/markets/equities/24/10/41629264/alphabets-earnings-rally-pushes-magnificent-7-market-cap-to-record-16-8-trillion-10-tech-heavy-e">Alphabet&#8217;s Earnings Rally Pushes Magnificent 7 Market Cap To Record $16.8 Trillion: 10 Tech-Heavy ETFs Moving Wednesday</a>
Outlook: Meta expects fourth-quarter revenue to be in the range of $45 billion to $48 billion versus an estimate of $46.31 billion. 
Meta expects full-year 2024 total expenses to be in the range of&nbsp;$96 billion to $98 billion, versus prior guidance of $96 to $99 billion. The company expects full-year 2024 capital expenditures to be in the range of&nbsp;$38 billion to $40 billion, versus its prior guidance range of&nbsp;$37 billion to $40 billion.
&#8220;For Reality Labs, we continue to expect 2024 operating losses to increase meaningfully year-over-year due to our ongoing product development efforts and investments to further scale our ecosystem,&#8221; the company said. 
Meta executives will hold a conference call to discuss the company&#8217;s quarterly results at 5 p.m. ET.
META Price Action:&nbsp;<a href="http://benzinga.com/quote/meta">Meta Platforms shares</a> were up approximately 68% year-to-date heading into the report. The stock was flat after-hours, trading at $592 at the time of publication Wednesday, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41633790/apple-refreshes-macbook-pro-lineup-with-m4-pro-and-m4-max-3nm-chips">Apple Refreshes MacBook Pro Lineup With M4 Pro and M4 Max 3Nm Chips</a></li>
</ul>
Photo: Shutterstock.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534;WATCH LIVE: Meta Platforms Q3 2024 Earnings Call &#x7C; $META" width="500" height="281" src="https://www.youtube.com/embed/MhZMnqaYVMM?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

After-Hours Center

Movers

Tech

Meta Platforms Q3 Earnings: Revenue Beat, EPS Beat, Daily Actives Up 5%, 'Strong Momentum' In AI (CORRECTED)

Hamilton Beach Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HBB#NYSE">HBB</a>) .

Guidance

Hamilton Beach Brands expects FY 2024 Cash Flow from operating activities less cash used for investing activities to be at the high end of $25M to $35M per year.

CORRECTION: Meta Platforms Sees Q4 Revenue $45B-$48B Vs $46.31B Est.

Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) sees Q4 sales of $333.000 million-338.000 million vs $329.28 million estimate.

TRUP

Trupanion Sees Q4 Sales $333.000M-338.000M vs $329.28M Est.

Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) raises FY2024 sales outlook from $1.26 billion-1.28 billion to $1.28 billion-1.29 billion.

Trupanion Raises FY2024 Sales Guidance from $1.26B-1.28B to $1.28B-1.29B.

The Company announced the appointment of Mr. Konstantinos Ferderigos as General Manager for its Greek Operations.&nbsp;
&nbsp;

Management

Advent Technologies Reveals Changes To Its Board And C-suite By Removing Chairman And CEO Vasilis Gregoriou And Chief Strategy Officer Chris Kaskavelis

Silicon Motion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIMO#NASDAQ">SIMO</a>) sees Q4 sales of $191.000 million-202.000 million vs $208.21 million estimate.

SIMO

Silicon Motion Technology Sees Q4 Sales $191.000M-202.000M vs $208.21M Est

Silicon Motion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIMO#NASDAQ">SIMO</a>) sees Q4 sales of $191.000 million-202.000 million.

Silicon Motion Technology Sees Q4 Sales $191.000M-202.000M

Carriage Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSV#NYSE">CSV</a>) raises FY2024 Adj EPS guidance from $2.30-2.40 to $2.45-2.55 vs $2.34 analyst estimate. Raises FY2024 sales outlook from $390.00 million-400.00 million to $395.00 million-405.00 million vs $395.76 million estimate.

Carriage Servs Raises FY2024 Adj EPS Guidance from $2.30-2.40 to $2.45-2.55 vs $2.34 Est; Raises FY2024 Sales Guidance from $390.00M-400.00M to $395.00M-405.00M vs $395.76M Est

From January 1, 2024 to October 30, 2024, the Company repurchased 1.28 million shares of common stock at a cost of approximately $165 million.&nbsp;
This authorization replenishes existing common stock repurchase program, bringing the total repurchase authorization to approximately 2 million shares, which represents approximately 5% of shares outstanding.

Buybacks

Boise Cascade Board Authorizes Repurchase Of Additional 1.4M Shares Of Common Stock Under Existing Common Stock Repurchase Program

Teladoc Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) shares are moving higher in extended trading Wednesday after the company reported financial results for the third quarter that <a href="https://www.benzinga.com/pressreleases/24/10/g41635843/teladoc-health-reports-third-quarter-2024-results">topped analyst expectations</a>.
<ul>
<li>Q3 Revenue: $640.51 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $631.16 million</li>
</ul>
<ul>
<li>Q3 EPS: Loss of 19 cents, versus estimates for a loss of 27 cents</li>
</ul>
Total revenue was down 3% on a year-over-year basis. Integrated Care segment revenue was up 2% year-over-year, while BetterHelp segment revenue declined 10% year-over-year. U.S. revenue fell 6% year-over-year, while International revenue grew 15%.
Cash flow from operations totaled $110.2 million in the third quarter. The company said it generated $79 million in free cash flow during the quarter.
&#8220;As we close out 2024, we are moving with urgency and making changes to more effectively leverage our leadership position in the complex and dynamic markets we serve. There is more work ahead of us, and 2025 will be an important repositioning year. Our focus remains on delivering consistent performance and driving long-term shareholder value,&#8221; said Chuck Divita, CEO of Teladoc Health.
Guidance: Teladoc expects fourth-quarter Integrated Care segment revenue to be flat to up 2.5% in the fourth quarter. The company expects full-year Integrated Care segment revenue to grow in the low single digits to mid-single digits.
TDOC Price Action: <a href="https://www.benzinga.com/quote/TDOC" target="_blank" rel="noreferrer noopener">Teladoc shares</a> were up 9.26 % in after-hours, trading at $9.68 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next: • <a href="https://www.benzinga.com/news/earnings/24/10/41637326/meta-platforms-q3-earnings-revenue-beat-eps-beat-daily-actives-up-5-strong-momentum-in-ai">Meta Platforms Q3 Earnings: Revenue Beat, EPS Beat, Daily Actives Up 5%, &#8216;Strong Momentum&#8217; In AI</a>
Photo: Courtesy of Teladoc.

Health Care

TDOC

Teladoc Health Q3 Earnings: Revenue Beat, EPS Beat, Shares Jump 10%

NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) affirms FY2024 sales outlook from $465.00 million-485.00 million to $465.00 million-485.00 million.

NNBR

NN Affirms FY2024 Sales Guidance from $465.00M-485.00M to $465.00M-485.00M

Tsai has served as our Interim CFO since April 25, 2024.

Silicon Motion Names Jason Tsai, Currently Its Interim CFO, As Finance Chief, Effective October 28, 2024

Silicon Motion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIMO#NASDAQ">SIMO</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.85 by 8.24 percent. The company reported quarterly sales of $212.412 million which beat the analyst consensus estimate of $209.470 million by 1.40 percent. This is a 23.26 percent increase over sales of $172.333 million the same period last year.

Silicon Motion Technology Q3 2024 Adj. EPS $0.92 Beats $0.85 Estimate, Sales $212.412M Beat $209.470M Estimate

NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 66.67 percent. The company reported quarterly sales of $113.587 million which missed the analyst consensus estimate of $120.501 million by 5.74 percent. This is a 8.72 percent decrease over sales of $124.443 million the same period last year.

Earnings Misses

NN Q3 2024 Adj. EPS $(0.05) Misses $(0.03) Estimate, Sales $113.587M Miss $120.501M Estimate

Excluding $1.0 million of net accretion income related to fair value adjustments, net income would have been $627,000 for the three months ended September 30, 2024.

SRBK

SR Bancorp September Quarter EPS $0.16, Up From $(10.03) Prior Year

NB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBBK#NASDAQ">NBBK</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.23 by 43.48 percent. The company reported $42.59 million in sales this quarter. This is a 16.29 percent increase over sales of $36.62 million the same period last year.

NBBK

NB Bancorp Q3 2024 Adj EPS $0.33 Beats $0.23 Estimate, Sales $42.59M Up From $36.62M YoY

Custom Truck One Source (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTOS#NYSE">CTOS</a>) narrows FY2024 sales outlook from $1.80 billion-1.98 billion to $1.80 billion-1.89 billion.

CTOS

Custom Truck One Source Narrows FY2024 Sales Guidance from $1.80B-1.98B to $1.80B-1.89B

JMP Securities analyst Constantine Davides maintained a Buy rating on Option Care Health (OPCH – Research Report) today and set a price target of $...

Buy Rating Affirmed for Option Care Health Amidst Market Shifts and Strong Valuation Prospects

Michael Petusky, an analyst from Barrington, maintained the Buy rating on Option Care Health (OPCH – Research Report). The associated price target ...

Option Care Health's Strategic Growth and Improved Profitability Justifies Buy Rating with $40 Target

Here's the major earnings before the open tomorrow

Option Care Health beats Q3 estimates

Comments taken from Q3 earnings conference call. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...

Option Care Health sees 'drastic,' 'rapid' impact in early 2025 from biosimilars

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Alphabet (GOOGL) reported upbeat Q3 re...

Alphabet, AMD report Q3 earnings beats: Morning Buzz

Option Care Health, Inc. (OPCH) Q3 2024 Earnings Call Transcript

JMP Securities analyst Constantine Davides has maintained their bullish stance on OPCH stock, giving a Buy rating on October 23. Constantine Davide...

Option Care Health: Strong Q3 Performance and Promising Growth Amidst Challenges

BofA downgraded Option Care Health (OPCH) to Neutral from Buy with a $29 price target Published first on TheFly – the ultimate source for real-time...

Option Care Health downgraded to Neutral from Buy at BofA

BofA analyst Kevin Fischbeck downgraded Option Care Health (OPCH) to Neutral from Buy with a price target of $29, down from $43. While the earnings...

Option Care Health downgraded to Neutral at BofA on Stelara risks

AAPL

ABBV

ARVN

ASPI

AXTA

BASFY

BIIB

BLKB

BPMC

COCO

CRMD

CRTO

CVEO

CWEN

EADSF

ENIC

EXTR

FLEX

FSLR

FVRR

GEHC

GOOG

GOOGL

GRMN

HESM

INMD

ITCI

IVPAF

LKNCY

NAVI

NBIX

NRDS

NVCR

OMCL

OPCH

OTIS

PUMP

QRVO

RDDT

ROCK

SHOP

SMCI

SNAP

Press Releases

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023

NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers

Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024

Option Care Health to Participate in the BofA Securities Health Care Conference

Option Care Health to Participate in Upcoming Investor Conferences

Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call

Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024

Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2024

BMRN

ENOV

IVCRQ

SYNH

TPTX

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Amedisys

AMN Healthcare Services

Astrana Health

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

Hims & Hers Health, Inc. Class A Common Stock

Hims & Hers Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Holdings

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

OPKO Health

Premier

Pennant Gr

Privia Health Gr

R1 RCM

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Hldgs

Barrington Research

JMP Securities

Jefferies

JP Morgan

Truist Securities

WIIM

Option Care Health shares are trading lower. The company reported Q3 financial results.

Comments

Option Care Health

Noticias

Últimas noticias sobre Option Care Health (NASDAQ:OPCH) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL